Persistent Corneal Epithelial Defect clinical trials

Explore recruiting persistent corneal epithelial defect clinical trials.

Recruiting persistent corneal epithelial defect studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Persistent Corneal Epithelial Defect trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicenter, controlled, randomized, observer-blinded clinical trial to evaluate the efficacy and safety of insulin eye drops (1 IU/ml) in the treatment of persistent corneal epithelial defect.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Recombinant Human Nerve Growth Factor Eye Drop Solution in Participants With Persistent Corneal Epithelial Defect (PCED)

Czechia, Italy, Netherlands, Poland, Germany, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON ® (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1)

Italy, Spain, Germany, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Persistent Corneal Epithelial Defect trials by city

Persistent Corneal Epithelial Defect in Toronto Persistent Corneal Epithelial Defect in Vancouver Persistent Corneal Epithelial Defect in Montreal Persistent Corneal Epithelial Defect in Calgary Persistent Corneal Epithelial Defect in Edmonton Persistent Corneal Epithelial Defect in Ottawa Persistent Corneal Epithelial Defect in Winnipeg Persistent Corneal Epithelial Defect in Quebec City Persistent Corneal Epithelial Defect in Hamilton Persistent Corneal Epithelial Defect in Kitchener Persistent Corneal Epithelial Defect in London Persistent Corneal Epithelial Defect in Halifax Persistent Corneal Epithelial Defect in New York Persistent Corneal Epithelial Defect in Los Angeles Persistent Corneal Epithelial Defect in Chicago Persistent Corneal Epithelial Defect in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease